HomeInsightsPE

Granules India Ltd PE Ratio

Granules India Ltd PE Ratio

stocks purchased

₹ 1.8 Cr

Volume transacted

stocks purchased

33.3 K

stocks traded

Last Updated time: 30 Oct 9.00 AM

Image

Granules India Ltd

NSE: GRANULES

PE

27.3

Last updated on: Oct 30, 2024

Key Highlights

  • The P/E Ratio of Granules India Ltd is 27.3 as of 30 Oct 9.00 AM.
  • The P/E Ratio of Granules India Ltd changed from 12.3 on March 2019 to 25.7 on March 2024 . This represents a CAGR of 13.07% over 6 years. .
  • The Latest Trading Price of Granules India Ltd is ₹ 554.5 as of 30 Oct 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.2. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Granules India Ltd

No data available

Company Fundamentals for Granules India Ltd

No data available

Image

Granules India Ltd

NSE: GRANULES

PRICE

554.5

0.20 (0.04%)

stock direction

Last updated on: Oct 30 03:30 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Granules India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
30 Oct 2024554.5
29 Oct 2024554.3
28 Oct 2024553
25 Oct 2024539.45
24 Oct 2024556.2
23 Oct 2024565.1
22 Oct 2024557.3
21 Oct 2024591.35
18 Oct 2024596.9
17 Oct 2024593.25

SWOT Analysis Of Granules India Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Granules India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Granules India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Granules India Ltd2713,439
Sun Pharmaceuticals Industries Ltd394,44,465
Divis Laboratories Ltd931,56,264
Cipla Ltd241,14,473
Torrent Pharmaceuticals Ltd611,06,171
Mankind Pharma Ltd531,05,299

Key Valuation Metric of Granules India Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Granules India Ltd

No data available

* All values are in crore

Historical Revenue of Granules India Ltd

No data available

* All values are in crore

Historical EBITDA of Granules India Ltd

No data available

* All values are in crore

Historical Net Profit of Granules India Ltd

No data available

* All values are in crore

Historical Dividend Payout of Granules India Ltd

No data available

* All values are in %

About Granules India Ltd

  • Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD).
  • With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
  • The company has a global presence across over 80 countries servicing over 300 customers.
  • Granules India is the preferred supplier for some of the world's leading pharma branded and generics companies.
  • The company has one of largest PFI and single site FD facilities in the world.

Granules India Ltd News Hub

News

Granules India Ltd soars 1.63%, up for third straight session

Granules India Ltd rose for a third straight session today. The stock is quoting at Rs 686...

Read more

2024-08-21 00:00:00

News

Granules Pharmaceuticals receives USFDA approval for Glycopyrrolate Oral Solution

Granules India announced today that the U.S. Food and Drug Administration (FDA) has approv...

Read more

2024-08-20 00:00:00

News

Granules India rises on USFDA nod for oral drug Glycopyrrolate

The ANDA has been filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign su...

Read more

2024-08-20 00:00:00

News

Granules India receives US FDA nod for depression treatment drug Trazodone

It is bioequivalent and therapeutically equivalent to the reference listed drug Desyrel Ta...

Read more

2024-08-09 00:00:00

News

Granules India receives USFDA approval for Trazodone Hydrochloride Tablets

Granules India announced today that the US Food & Drug Administration (US FDA) has approve...

Read more

2024-08-09 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Granules India Ltd

What is the current PE Ratio of Granules India Ltd?

The Current PE Ratio of Granules India Ltd is 27.32 as on 30 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 30 Oct 2024.

What was the PE Ratio of Granules India Ltd last year?

The PE Ratio of Granules India Ltd was 13.62 last year, now the PE ratio is 27.32, showing a year-on-year growth of 100.6%.

What does the PE Ratio of Granules India Ltd indicate about its stock?

The PE Ratio of Granules India Ltd is 27.32. This ratio indicates that investors are willing to pay 27.32 times the earnings per share for each share of Granules India Ltd.

What is the PE Ratio Growth of Granules India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Granules India Ltd grew by 100.6% whereas, the EPS ratio grew by 3.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*